Announcement of Requirements and Registration for “A Wearable Alcohol Biosensor” Challenge, 11208-11210 [2015-04254]
Download as PDF
11208
Federal Register / Vol. 80, No. 40 / Monday, March 2, 2015 / Notices
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
All written comments will be
available for public inspection on
Regulations.gov.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
Comment Due Date: Your comments
regarding this information collection are
best assured of having full effect if
received within 30 days of the date of
this publication.
a useful alcohol biosensor in the near
future. The NIH believes that this
challenge will stimulate investment
from public and private sectors in the
development of functional alcohol
biosensors that will be appealing to
individuals, treatment providers, and
researchers.
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Submission period begins March 2,
2015, 9:00 a.m. ET.
Submission period ends: December 1,
2015.
Judging period: January 2016.
Winners announced: On or after
February 15, 2016.
The NIH will announce any changes
to this timeline by amending this
Federal Register notice.
FOR FURTHER INFORMATION CONTACT: M.
Katherine Jung, Ph.D., Program Director,
Division of Metabolism and Health
Effects, National Institute on Alcohol
Abuse and Alcoholism, Phone: 301–
443–8744, Email Kathy.jung@nih.gov.
F.L. Dammann, M.P.A., Management
Analyst and Special Assistant to the
Executive, National Institute on Alcohol
Abuse and Alcoholism, Phone: 301–
480–9433, Email: fl.dammann@nih.gov.
SUPPLEMENTARY INFORMATION:
National Institutes of Health
Subject of Challenge
Dated: February 20, 2015.
Robert G. McSwain,
Acting Director, Indian Health Service.
[FR Doc. 2015–04112 Filed 2–27–15; 8:45 am]
BILLING CODE 4165–16–P
Announcement of Requirements and
Registration for ‘‘A Wearable Alcohol
Biosensor’’ Challenge
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Authority: 15 U.S.C. 3719.
Award Approving Official: Dr.
Lawrence A. Tabak, Principal Deputy
Director, National Institutes of Health
(NIH).
SUMMARY: Through the ‘‘A Wearable
Alcohol Biosensor’’ Challenge (the
‘‘Challenge’’), the National Institute on
Alcohol Abuse and Alcoholism
(NIAAA), a component of the National
Institutes of Health (NIH), is searching
for a wearable or otherwise discreet
device capable of measuring blood
alcohol level in real time. The advent of
alcohol biosensors that can be worn
discreetly and used by individuals in
the course of their daily lives will
advance the mission of NIAAA in the
arenas of research, treatment, and
rehabilitation. NIAAA has supported
academic and small business grants and
contracts to advance the development
and use of alcohol biosensors in the
past. Current technological
developments in electronics,
miniaturization, wireless technology,
and biophysical techniques of alcohol
detection in humans increase the
likelihood of successful development of
VerDate Sep<11>2014
16:55 Feb 27, 2015
Jkt 235001
Current technologies for real time
monitoring of alcohol consumption,
used in criminal justice applications,
have performed adequately, but have
disadvantages for broader use.
NIAAA seeks the design and
production of a wearable device to
monitor blood alcohol levels in real
time. The device should be
inconspicuous, low profile, and
appealing to the wearer. The design can
take the form of jewelry, clothing, or any
other format located in contact with the
human body. A non-invasive technology
is preferred.
Current technology for continuous
alcohol monitoring takes a reading every
30 minutes. We are seeking a solution
that improves on this interval and most
closely approximates real time
monitoring and data collection. The
device should be able to quantitate
blood alcohol level, interpret and store
the data, or transmit it to a smartphone
or other device by wireless
transmission. Data storage and
transmission must be completely secure
in order to protect the privacy of the
individual. The device should have the
ability to verify standardization at
regular intervals and to indicate loss of
functionality. The power source should
be dependable and rechargeable. A form
of subject identification would be an
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
added benefit. The device can be
removable.
This is a reduction to practice
challenge that requires written
documentation and a working prototype
of the submitted solution.
NIAAA is open to a range of design
forms which can accomplish the above
tasks.
Statutory Authority of the Funding
Source
This Challenge is consistent with and
advances the mission of NIAAA, as
described in 42 U.S.C. 285n, to conduct
and support biomedical and behavioral
research, health services research,
research training, and health
information dissemination with respect
to the prevention of alcohol abuse and
the treatment of alcoholism, and to
conduct a study of alternative
approaches for alcoholism and alcohol
abuse treatment and rehabilitation.
Eligibility Rules for the Challenge
1. To Participate
This Challenge is open to any
‘‘Solver’’ where ‘‘Solver’’ is defined as
an individual, a group of individuals
(i.e., a team), or an entity. Whether
singly or as part of a group or entity,
individuals younger than 18
participating in the Challenge must
provide parental consent and must
abide by the Children’s Online Privacy
Protection Act.
2. To Win
To be eligible to win a prize under
this Challenge, the Solver—
1. Shall have registered to participate
in the Challenge at www.challenge.gov.
2. Shall have complied with all the
requirements under this section on
Eligibility.
3. In the case of a private entity, shall
be incorporated in and maintain a
primary place of business in the United
States; and in the case of an individual,
whether participating singly or in a
group, shall be a citizen or permanent
resident of the United States. Note: NonU.S. citizens and nonpermanent
residents can participate as a member of
a team that otherwise satisfies the
eligibility criteria but will not be eligible
to win a monetary prize (in whole or in
part); however, their participation as
part of a winning team, if applicable,
may be recognized when results are
announced.
4. In the case of an individual, he/she
may not be an employee of the NIH; an
individual involved in formulation of
the Challenge and/or serving on the
technical evaluation panel; any other
individual involved with the design,
E:\FR\FM\02MRN1.SGM
02MRN1
Federal Register / Vol. 80, No. 40 / Monday, March 2, 2015 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
production, execution, distribution, or
evaluation of this Challenge; or
members of the individual’s immediate
family (specifically, a parent,
stepparent, spouse, domestic partner,
child, sibling, or step-sibling).
5. An individual, team, or entity that
is currently on the Excluded Parties List
(https://www.epls.gov/) will not be
selected as a Finalist or prize winner.
6. In the case of an entity, may not be
a federal entity; and in the case of an
individual, may not be a federal
employee acting within the scope of his
or her employment.
7. Federal employees otherwise
permitted to participate in the Challenge
shall not work on their submission
during assigned duty hours. Note:
Federal ethical conduct rules may
restrict or prohibit federal employees
from engaging in certain outside
activities, so any federal employee not
excluded under the prior paragraph
seeking to participate in this Challenge
outside the scope of employment should
consult his/her agency’s ethics official
prior to developing a submission.
8. Federal grantees may not use
federal funds to develop Challenge
submissions.
9. Federal contractors may not use
federal funds from a contract to develop
Challenge submissions or to fund efforts
in support of a Challenge submission.
10. An individual shall not be deemed
ineligible to win because the individual
used federal facilities or consulted with
federal employees during the Challenge
provided that such facilities and/or
employees, as applicable, are made
available on an equitable basis to all
individuals and teams participating in
the Challenge. All questions regarding
the Challenge should be directed to Dr.
Jung or Mr. Dammann, identified above,
and answers will be posted and updated
as necessary at https://
www.niaaa.nih.gov/research/challengeprize under Frequently Asked
Questions. Questions from Solvers that
may reveal proprietary information
related to solutions under development
addressed to NIAAA will be held in
strictest confidence.
Submission Requirements
The submission to the Challenge
should include the following:
(1) The final solution set for challenge
award must include reduction to
practice of a working prototype of a
wearable alcohol biosensor.
(2) Solutions should also include
written evidence of successful data
storage and retrieval, of consistent
function, reliability and robust
reproducibility of alcohol
quantification. A detailed description of
VerDate Sep<11>2014
16:55 Feb 27, 2015
Jkt 235001
the proposed Solution must include an
instructive account of the method of
alcohol detection, interval of data
sampling, the means of subject
identification, proposed process of
manufacture, verification of data
security and integrity, and
standardization of measurements.
(3) Image or images of the proposed
wearable, to include overall dimensions.
(4) A video demonstrating the
wearable’s required capabilities.
Registration and Submission Process
for Solvers
11209
Challenge Judges
Director, National Institute on Alcohol
Abuse and Alcoholism
A senior staff member from the National
Institute of Biomedical Imaging and
Bioengineering
One or more members from the National
Advisory Council of the National
Institute on Alcohol Abuse and
Alcoholism
Program Staff from the National
Institute on Alcohol Abuse and
Alcoholism
Amount of the Prize
First Prize: $200,000
Second Prize: $100,000
The NIH reserves the right to cancel,
suspend, and/or modify this Challenge
at any time through amendment to this
Federal Register notice. In addition, the
NIH reserves the right to not award any
prizes if no solutions are deemed
worthy. The award approving official
for this Challenge is the NIH Principal
Deputy Director.
The challenge judges will be advised
by a technical panel consisting of
individuals with expertise in the
following areas:
Chemistry
Engineering
Information Technology and
Information System Security
Behavioral and Social Sciences
Development of vehicular alcohol
detection systems
Additional Information
Solvers must register and submit their
Solutions on www.challenge.gov Web
site under the link for ‘‘A Wearable
Alcohol Biosensor’’.
Payment of the Prize
Prizes awarded under this
competition will be paid by electronic
funds transfer and may be subject to
Federal income taxes. NIAAA will
comply with the Internal Revenue
Service withholding and reporting
requirements, where applicable.
Basis Upon Which Winners Will Be
Evaluated
Submissions will be judged by a
qualified panel selected by NIAAA. The
panel will evaluate submissions based
on the following judging criteria:
1. Accuracy, reliability, and frequency
of blood alcohol measurement
2. Functionality, accuracy, and
integration of data collection, data
transmission and data storage
3. Safeguards for privacy protection and
data integrity
4. Plans for process of manufacture
5. Marketability and likelihood of
bringing the product to market
6. Appeal and acceptability to wearers
7. Feasibility
The award is contingent upon
experimental validation of the
submitted Solution by the Seeker.
During the judging period, the expert
panel may request additional
information or clarification in order to
evaluate the entry.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Intellectual Property: By submitting
the Submission, each Solver warrants
that he or she is the sole author and
owner of any patentable works that the
Submission comprises, that the works
are wholly original with the Solver (or
is an improved version of an existing
work that the Solver has sufficient rights
to use and improve), and that the
Submission does not infringe on any
copyright, patent or any other rights of
any third party of which Solver is
aware. To receive an award, Solvers will
not be required to transfer their
exclusive intellectual property rights to
the NIH. Instead, Solvers will grant to
the federal government a nonexclusive
license to practice their solutions and
use the materials that describe them. To
participate in the Challenge, each Solver
must warrant that there are no legal
obstacles to providing a nonexclusive
license of Solver’s rights to the federal
government. This license will grant to
the United States government a
nonexclusive, nontransferable,
irrevocable, paid-up license to practice
or have practiced for or on behalf of the
United States throughout the world any
invention made by the Solvers that
covers the Submission. In addition, the
license will grant to the federal
government and others acting on its
behalf, a paid-up, nonexclusive,
irrevocable, worldwide license in any
copyrightable works that the
Submission comprises, including the
right to reproduce, prepare derivative
works, distribute copies to the public,
and perform publicly and display
publicly said copyrightable works.
E:\FR\FM\02MRN1.SGM
02MRN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
11210
Federal Register / Vol. 80, No. 40 / Monday, March 2, 2015 / Notices
Liability and Indemnification: By
participating in this Challenge, each
Solver agrees to assume any and all
risks and waive claims against the
federal government and its related
entities, except in the case of willful
misconduct, for any injury, death,
damage, or loss of property, revenue, or
profits, whether direct, indirect, or
consequential, arising from
participation in this Challenge, whether
the injury, death, damage, or loss arises
through negligence or otherwise. By
participating in this Challenge, each
Solver agrees to indemnify the federal
government against third party claims
for damages arising from or related to
Challenge activities.
Insurance: Based on the subject
matter of the Challenge, the type of
work that it will possibly require, as
well as an analysis of the likelihood of
any claims for death, bodily injury, or
property damage, or loss potentially
resulting from competition
participation. Solvers are not required to
obtain liability insurance or
demonstrate financial responsibility in
order to participate in this Challenge.
Privacy, Data Security, Ethics, and
Compliance: Solvers are required to
identify and address privacy and
security issues in their proposed
projects and describe specific solutions
for meeting them. In addition to
complying with appropriate policies,
procedures, and protections for data that
ensures all privacy requirements and
institutional policies are met, use of
data should not allow the identification
of the individual from whom the data
was collected. Solvers are responsible
for compliance with all applicable
federal, state, local, and institutional
laws, regulations, and policies. These
may include, but are not limited to,
Health Information Portability and
Accountability Act (HIPAA) protections,
Department of Health and Human
Services (HHS) Protection of Human
Subjects regulations, and Food and Drug
Administration (FDA) regulations. It is
the responsibility of the Solver to obtain
approvals (e.g., from an Institutional
Review Board), if required. The
following links are intended as a
starting point for addressing regulatory
requirements but should not be
interpreted as a complete list of
resources on these issues:
HIPAA
Main link: https://www.hhs.gov/ocr/
privacy/.
Summary of the HIPAA Privacy Rule:
https://www.hhs.gov/ocr/privacy/
VerDate Sep<11>2014
16:55 Feb 27, 2015
Jkt 235001
hipaa/understanding/summary/
index.html.
Summary of the HIPAA Security Rule:
https://www.hhs.gov/ocr/privacy/
hipaa/understanding/
srsummary.html.
Human Subjects—HHS
Office for Human Research Protections:
https://www.hhs.gov/ohrp/.
Protection of Human Subjects
Regulations: https://www.hhs.gov/
ohrp/humansubjects/guidance/
45cfr46.html.
Policy & Guidance: https://www.hhs.gov/
ohrp/policy/.
Institutional Review Boards
&Assurances: https://www.hhs.gov/
ohrp/assurances/.
Human Subjects—FDA
Clinical Trials: https://www.fda.gov/
ScienceResearch/SpecialTopics/
RunningClinicalTrials/default.htm.
Office of Good Clinical Practice:
https://www.fda.gov/AboutFDA/
CentersOffices/
OfficeofMedicalProductsandTobacco/
OfficeofScienceandHealthCoordination/
ucm2018191.
Consumer Protection—Federal Trade
Commission
Bureau of Consumer Protection:
https://business.ftc.gov/privacy-andsecurity.
Dated: February 23, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015–04254 Filed 2–27–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; The Genetic
Testing Registry
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on November 25,
2014, page 70194 and allowed 60 days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
30 days for public comment. The Office
of the Director (OD), National Institutes
of Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Ms. Sarah Carr, Acting Director,
Office of Clinical Research and
Bioethics Policy, Office of Science
Policy, NIH, 6705 Rockledge Dr., Suite
750, Bethesda, MD 20892, or call nontoll-free number (301) 496–9838, or
Email your request, including your
address to: OCRBP-OSP@od.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: The Genetic
Testing Registry, 0925–0651,
EXTENSION—Office of the Director
(OD), National Institutes of Health
(NIH).
Need and Use of Information
Collection: Clinical laboratory tests are
available for more than 5,000 genetic
conditions. The Genetic Testing Registry
(GTR) provides a centralized, online
location for test developers,
manufacturers, and researchers to
voluntarily submit detailed information
about the availability and scientific
basis of their genetic tests. The GTR is
of value to clinicians by providing
information about the accuracy,
validity, and usefulness of genetic tests.
The GTR also highlights evidence gaps
where additional research is needed.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
5,536.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 80, Number 40 (Monday, March 2, 2015)]
[Notices]
[Pages 11208-11210]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04254]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Announcement of Requirements and Registration for ``A Wearable
Alcohol Biosensor'' Challenge
Authority: 15 U.S.C. 3719.
Award Approving Official: Dr. Lawrence A. Tabak, Principal Deputy
Director, National Institutes of Health (NIH).
SUMMARY: Through the ``A Wearable Alcohol Biosensor'' Challenge (the
``Challenge''), the National Institute on Alcohol Abuse and Alcoholism
(NIAAA), a component of the National Institutes of Health (NIH), is
searching for a wearable or otherwise discreet device capable of
measuring blood alcohol level in real time. The advent of alcohol
biosensors that can be worn discreetly and used by individuals in the
course of their daily lives will advance the mission of NIAAA in the
arenas of research, treatment, and rehabilitation. NIAAA has supported
academic and small business grants and contracts to advance the
development and use of alcohol biosensors in the past. Current
technological developments in electronics, miniaturization, wireless
technology, and biophysical techniques of alcohol detection in humans
increase the likelihood of successful development of a useful alcohol
biosensor in the near future. The NIH believes that this challenge will
stimulate investment from public and private sectors in the development
of functional alcohol biosensors that will be appealing to individuals,
treatment providers, and researchers.
DATES:
Submission period begins March 2, 2015, 9:00 a.m. ET.
Submission period ends: December 1, 2015.
Judging period: January 2016.
Winners announced: On or after February 15, 2016.
The NIH will announce any changes to this timeline by amending this
Federal Register notice.
FOR FURTHER INFORMATION CONTACT: M. Katherine Jung, Ph.D., Program
Director, Division of Metabolism and Health Effects, National Institute
on Alcohol Abuse and Alcoholism, Phone: 301-443-8744, Email
Kathy.jung@nih.gov. F.L. Dammann, M.P.A., Management Analyst and
Special Assistant to the Executive, National Institute on Alcohol Abuse
and Alcoholism, Phone: 301-480-9433, Email: fl.dammann@nih.gov.
SUPPLEMENTARY INFORMATION:
Subject of Challenge
Current technologies for real time monitoring of alcohol
consumption, used in criminal justice applications, have performed
adequately, but have disadvantages for broader use.
NIAAA seeks the design and production of a wearable device to
monitor blood alcohol levels in real time. The device should be
inconspicuous, low profile, and appealing to the wearer. The design can
take the form of jewelry, clothing, or any other format located in
contact with the human body. A non-invasive technology is preferred.
Current technology for continuous alcohol monitoring takes a
reading every 30 minutes. We are seeking a solution that improves on
this interval and most closely approximates real time monitoring and
data collection. The device should be able to quantitate blood alcohol
level, interpret and store the data, or transmit it to a smartphone or
other device by wireless transmission. Data storage and transmission
must be completely secure in order to protect the privacy of the
individual. The device should have the ability to verify
standardization at regular intervals and to indicate loss of
functionality. The power source should be dependable and rechargeable.
A form of subject identification would be an added benefit. The device
can be removable.
This is a reduction to practice challenge that requires written
documentation and a working prototype of the submitted solution.
NIAAA is open to a range of design forms which can accomplish the
above tasks.
Statutory Authority of the Funding Source
This Challenge is consistent with and advances the mission of
NIAAA, as described in 42 U.S.C. 285n, to conduct and support
biomedical and behavioral research, health services research, research
training, and health information dissemination with respect to the
prevention of alcohol abuse and the treatment of alcoholism, and to
conduct a study of alternative approaches for alcoholism and alcohol
abuse treatment and rehabilitation.
Eligibility Rules for the Challenge
1. To Participate
This Challenge is open to any ``Solver'' where ``Solver'' is
defined as an individual, a group of individuals (i.e., a team), or an
entity. Whether singly or as part of a group or entity, individuals
younger than 18 participating in the Challenge must provide parental
consent and must abide by the Children's Online Privacy Protection Act.
2. To Win
To be eligible to win a prize under this Challenge, the Solver--
1. Shall have registered to participate in the Challenge at
www.challenge.gov.
2. Shall have complied with all the requirements under this section
on Eligibility.
3. In the case of a private entity, shall be incorporated in and
maintain a primary place of business in the United States; and in the
case of an individual, whether participating singly or in a group,
shall be a citizen or permanent resident of the United States. Note:
Non- U.S. citizens and nonpermanent residents can participate as a
member of a team that otherwise satisfies the eligibility criteria but
will not be eligible to win a monetary prize (in whole or in part);
however, their participation as part of a winning team, if applicable,
may be recognized when results are announced.
4. In the case of an individual, he/she may not be an employee of
the NIH; an individual involved in formulation of the Challenge and/or
serving on the technical evaluation panel; any other individual
involved with the design,
[[Page 11209]]
production, execution, distribution, or evaluation of this Challenge;
or members of the individual's immediate family (specifically, a
parent, stepparent, spouse, domestic partner, child, sibling, or step-
sibling).
5. An individual, team, or entity that is currently on the Excluded
Parties List (https://www.epls.gov/) will not be selected as a Finalist
or prize winner.
6. In the case of an entity, may not be a federal entity; and in
the case of an individual, may not be a federal employee acting within
the scope of his or her employment.
7. Federal employees otherwise permitted to participate in the
Challenge shall not work on their submission during assigned duty
hours. Note: Federal ethical conduct rules may restrict or prohibit
federal employees from engaging in certain outside activities, so any
federal employee not excluded under the prior paragraph seeking to
participate in this Challenge outside the scope of employment should
consult his/her agency's ethics official prior to developing a
submission.
8. Federal grantees may not use federal funds to develop Challenge
submissions.
9. Federal contractors may not use federal funds from a contract to
develop Challenge submissions or to fund efforts in support of a
Challenge submission.
10. An individual shall not be deemed ineligible to win because the
individual used federal facilities or consulted with federal employees
during the Challenge provided that such facilities and/or employees, as
applicable, are made available on an equitable basis to all individuals
and teams participating in the Challenge. All questions regarding the
Challenge should be directed to Dr. Jung or Mr. Dammann, identified
above, and answers will be posted and updated as necessary at https://www.niaaa.nih.gov/research/challenge-prize under Frequently Asked
Questions. Questions from Solvers that may reveal proprietary
information related to solutions under development addressed to NIAAA
will be held in strictest confidence.
Submission Requirements
The submission to the Challenge should include the following:
(1) The final solution set for challenge award must include
reduction to practice of a working prototype of a wearable alcohol
biosensor.
(2) Solutions should also include written evidence of successful
data storage and retrieval, of consistent function, reliability and
robust reproducibility of alcohol quantification. A detailed
description of the proposed Solution must include an instructive
account of the method of alcohol detection, interval of data sampling,
the means of subject identification, proposed process of manufacture,
verification of data security and integrity, and standardization of
measurements.
(3) Image or images of the proposed wearable, to include overall
dimensions.
(4) A video demonstrating the wearable's required capabilities.
Registration and Submission Process for Solvers
Solvers must register and submit their Solutions on
www.challenge.gov Web site under the link for ``A Wearable Alcohol
Biosensor''.
Amount of the Prize
First Prize: $200,000
Second Prize: $100,000
The NIH reserves the right to cancel, suspend, and/or modify this
Challenge at any time through amendment to this Federal Register
notice. In addition, the NIH reserves the right to not award any prizes
if no solutions are deemed worthy. The award approving official for
this Challenge is the NIH Principal Deputy Director.
Payment of the Prize
Prizes awarded under this competition will be paid by electronic
funds transfer and may be subject to Federal income taxes. NIAAA will
comply with the Internal Revenue Service withholding and reporting
requirements, where applicable.
Basis Upon Which Winners Will Be Evaluated
Submissions will be judged by a qualified panel selected by NIAAA.
The panel will evaluate submissions based on the following judging
criteria:
1. Accuracy, reliability, and frequency of blood alcohol measurement
2. Functionality, accuracy, and integration of data collection, data
transmission and data storage
3. Safeguards for privacy protection and data integrity
4. Plans for process of manufacture
5. Marketability and likelihood of bringing the product to market
6. Appeal and acceptability to wearers
7. Feasibility
The award is contingent upon experimental validation of the
submitted Solution by the Seeker. During the judging period, the expert
panel may request additional information or clarification in order to
evaluate the entry.
Challenge Judges
Director, National Institute on Alcohol Abuse and Alcoholism
A senior staff member from the National Institute of Biomedical Imaging
and Bioengineering
One or more members from the National Advisory Council of the National
Institute on Alcohol Abuse and Alcoholism
Program Staff from the National Institute on Alcohol Abuse and
Alcoholism
The challenge judges will be advised by a technical panel
consisting of individuals with expertise in the following areas:
Chemistry
Engineering
Information Technology and Information System Security
Behavioral and Social Sciences
Development of vehicular alcohol detection systems
Additional Information
Intellectual Property: By submitting the Submission, each Solver
warrants that he or she is the sole author and owner of any patentable
works that the Submission comprises, that the works are wholly original
with the Solver (or is an improved version of an existing work that the
Solver has sufficient rights to use and improve), and that the
Submission does not infringe on any copyright, patent or any other
rights of any third party of which Solver is aware. To receive an
award, Solvers will not be required to transfer their exclusive
intellectual property rights to the NIH. Instead, Solvers will grant to
the federal government a nonexclusive license to practice their
solutions and use the materials that describe them. To participate in
the Challenge, each Solver must warrant that there are no legal
obstacles to providing a nonexclusive license of Solver's rights to the
federal government. This license will grant to the United States
government a nonexclusive, nontransferable, irrevocable, paid-up
license to practice or have practiced for or on behalf of the United
States throughout the world any invention made by the Solvers that
covers the Submission. In addition, the license will grant to the
federal government and others acting on its behalf, a paid-up,
nonexclusive, irrevocable, worldwide license in any copyrightable works
that the Submission comprises, including the right to reproduce,
prepare derivative works, distribute copies to the public, and perform
publicly and display publicly said copyrightable works.
[[Page 11210]]
Liability and Indemnification: By participating in this Challenge,
each Solver agrees to assume any and all risks and waive claims against
the federal government and its related entities, except in the case of
willful misconduct, for any injury, death, damage, or loss of property,
revenue, or profits, whether direct, indirect, or consequential,
arising from participation in this Challenge, whether the injury,
death, damage, or loss arises through negligence or otherwise. By
participating in this Challenge, each Solver agrees to indemnify the
federal government against third party claims for damages arising from
or related to Challenge activities.
Insurance: Based on the subject matter of the Challenge, the type
of work that it will possibly require, as well as an analysis of the
likelihood of any claims for death, bodily injury, or property damage,
or loss potentially resulting from competition participation. Solvers
are not required to obtain liability insurance or demonstrate financial
responsibility in order to participate in this Challenge.
Privacy, Data Security, Ethics, and Compliance: Solvers are
required to identify and address privacy and security issues in their
proposed projects and describe specific solutions for meeting them. In
addition to complying with appropriate policies, procedures, and
protections for data that ensures all privacy requirements and
institutional policies are met, use of data should not allow the
identification of the individual from whom the data was collected.
Solvers are responsible for compliance with all applicable federal,
state, local, and institutional laws, regulations, and policies. These
may include, but are not limited to, Health Information Portability and
Accountability Act (HIPAA) protections, Department of Health and Human
Services (HHS) Protection of Human Subjects regulations, and Food and
Drug Administration (FDA) regulations. It is the responsibility of the
Solver to obtain approvals (e.g., from an Institutional Review Board),
if required. The following links are intended as a starting point for
addressing regulatory requirements but should not be interpreted as a
complete list of resources on these issues:
HIPAA
Main link: https://www.hhs.gov/ocr/privacy/.
Summary of the HIPAA Privacy Rule: https://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/.
Summary of the HIPAA Security Rule: https://www.hhs.gov/ocr/privacy/hipaa/understanding/srsummary.html.
Human Subjects--HHS
Office for Human Research Protections: https://www.hhs.gov/ohrp/.
Protection of Human Subjects Regulations: https://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html.
Policy & Guidance: https://www.hhs.gov/ohrp/policy/.
Institutional Review Boards &Assurances: https://www.hhs.gov/ohrp/assurances/.
Human Subjects--FDA
Clinical Trials: https://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/default.htm.
Office of Good Clinical Practice: https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/OfficeofScienceandHealthCoordination/ucm2018191.
Consumer Protection--Federal Trade Commission
Bureau of Consumer Protection: https://business.ftc.gov/privacy-and-security.
Dated: February 23, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015-04254 Filed 2-27-15; 8:45 am]
BILLING CODE 4140-01-P